News - Page 219 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Post published:January 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Post published:January 26, 2021
Post category:Press Release

Read more about the article Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Post published:January 26, 2021
Post category:Press Release

Read more about the article Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

Post published:January 25, 2021
Post category:Press Release

Read more about the article PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

Post published:January 25, 2021
Post category:Press Release

Read more about the article Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Post published:January 25, 2021
Post category:Press Release

Read more about the article Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Post published:January 25, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Psychedelics Index Published; ETF Launching Jan 27; MindMed Commences Candyflipping Trial

Psychedelic Bulletin: Psychedelics Index Published; ETF Launching Jan 27; MindMed Commences Candyflipping Trial

Post published:January 22, 2021
Post category:Psychedelic Bulletin

Read more about the article Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Post published:January 22, 2021
Post category:Press Release

Read more about the article Horizons ETFs to Launch World’s First Psychedelics-Focused ETF

Horizons ETFs to Launch World’s First Psychedelics-Focused ETF

Post published:January 22, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.